Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : ELDN save search
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
| Email alert
Add to watchlist
year pharmaceuticals financial results
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
Published: 2024-03-25 (Crawled : 21:00) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: -1.45%
H: 4.9%
C: 3.92%
pharmaceuticals trial
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
Published: 2024-03-21 (Crawled : 14:30) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: -1.78%
H: 15.66%
C: 13.25%
kidney pharmaceuticals
Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million, 42% of market growth is expected in North America, Technavio
Published: 2024-03-12 (Crawled : 04:00) - prnewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: 1.73%
H: 1.7%
C: -7.39%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
DNLI | $15.55 -3.48% -3.6% 940K
|
Health Technology
|
| O: -0.6%
H: 0.74%
C: -3.66%
BCLI A | $0.5339 1.7% 1.67% 190K
|
Health Technology
|
| O: -2.43%
H: 2.8%
C: -4.02%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: -0.32%
H: 0.18%
C: -0.86%
expected sclerosis treatment growth market
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 14, 2024
Published: 2024-02-14 (Crawled : 10:00) - biospace.com/
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: 5.2%
H: 0.0%
C: -2.75%
nasdaq grants
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-02-14 (Crawled : 00:00) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: 5.2%
H: 0.0%
C: -2.75%
nasdaq grants
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
Published: 2024-01-04 (Crawled : 22:00) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: 3.8%
H: 0.0%
C: -4.19%
business pharmaceuticals
Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million from 2023 to 2028, North America to account for 42% of market growth - Technavio
Published: 2023-12-07 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 2.06%
H: 0.82%
C: 0.82%
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: -1.59%
H: 7.26%
C: 2.42%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
DNLI | $15.55 -3.48% -3.6% 940K
|
Health Technology
|
| O: -0.21%
H: 0.08%
C: -1.76%
BCLI A | $0.5339 1.7% 1.67% 190K
|
Health Technology
|
| O: 0.0%
H: 3.56%
C: -9.77%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: -0.61%
H: 1.33%
C: 0.69%
america sclerosis treatment growth market
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-12-04 (Crawled : 23:00) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: 3.01%
H: 0.73%
C: -5.84%
nasdaq grants
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
Published: 2023-11-29 (Crawled : 00:00) - biospace.com/
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: -1.67%
H: 0.85%
C: -5.08%
conference pharmaceuticals growth
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: 1.74%
H: 3.41%
C: -0.85%
pharmaceuticals financial results
Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference
Published: 2023-11-08 (Crawled : 21:00) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: -4.13%
H: 2.58%
C: -0.86%
conference pharmaceuticals
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
Published: 2023-11-02 (Crawled : 13:00) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: 1.48%
H: 0.0%
C: -11.68%
kidney ongoing trial
Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer
Published: 2023-10-23 (Crawled : 11:00) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: -3.7%
H: 7.04%
C: 6.24%
pharmaceuticals medical
Eledon Pharmaceuticals to Present Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Society of Nephrology Kidney Week 2023 Annual Meeting
Published: 2023-10-13 (Crawled : 11:00) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: 0.0%
H: 3.42%
C: 1.37%
kidney ongoing pharmaceuticals meeting week trial
Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors
Published: 2023-10-02 (Crawled : 11:00) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: 6.57%
H: 8.9%
C: 6.16%
kidney pharmaceuticals specialist
Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human
Published: 2023-09-25 (Crawled : 11:00) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: 7.44%
H: 2.31%
C: -6.92%
cd40 antibody pharmaceuticals heart
Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
Published: 2023-09-20 (Crawled : 20:00) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: -1.64%
H: 4.17%
C: 2.5%
conference pharmaceuticals global
Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
Published: 2023-09-11 (Crawled : 11:00) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: 3.73%
H: 1.08%
C: -5.04%
URGN | $14.24 -2.0% -2.04% 97K
|
Health Technology
|
| O: 0.54%
H: 2.64%
C: 0.12%
pharmaceuticals
Eledon Pharmaceuticals Announces Publication of Data Showing Treatment with Tegoprubart Promotes Kidney and Islet Allograft Survival and Function in Nonhuman Primates
Published: 2023-09-06 (Crawled : 11:00) - globenewswire.com
ELDN | $1.96 -9.26% -10.2% 100K
|
Manufacturing
|
| O: 18.88%
H: 0.0%
C: -25.88%
kidney publication treatment pharmaceuticals
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.